Namita Thapar’s Emcure Pharma Debuts with 31% Premium
The IPO is managed by Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited, and Jefferies
Namita Thapar Will Get 293-Fold Return on Her
Namita Thapar stands to gain a remarkable 293-fold return on her initial investment. New Delhi: Namita Thapar, the Executive Director